Colt CZ Group (CZG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jun, 2025Executive summary
Revenues rose 50.6% year-over-year to CZK 22,376m in 2024, driven by organic growth and the Sellier & Bellot acquisition.
Adjusted EBITDA increased 50.9% to CZK 4,599m, with pro forma adjusted EBITDA at CZK 5,430m, up 78.1% year-over-year.
Adjusted net profit was CZK 1,933m, down 5.7% year-over-year, mainly due to higher interest costs and one-offs.
Net leverage reduced to 2.26x post-ABB, with strong cash generation supporting future deleveraging.
Board proposes CZK 847m cash dividend (CZK 15/share) and CZK 847m share buyback for 2024, each representing 50% of profit distribution.
Financial highlights
Pro forma revenues including S&B: CZK 25,095m, up 68.9% year-over-year.
Firearms sold increased 2.0% year-over-year to 634,000 units, with long firearms up 13.4% and handguns down 5.5%.
Firearms and accessories segment revenue: CZK 15.4bn; ammunition: CZK 6.9bn (including S&B from May 2024).
Adjusted EBITDA margin for the group: 21% in 2024.
CAPEX for 2024 was CZK 921m, in line with guidance (up to 5% of revenues).
Outlook and guidance
2025 revenue guidance: CZK 25bn (+12% yoy, ±7%); EBITDA: CZK 5.5bn (+20% yoy, ±7%).
Net interest costs for 2025 expected at CZK 631m, with stable FX and interest rate assumptions.
Capital expenditures for 2025 expected at CZK 1.1–1.3bn (approx. 5% of expected revenues).
Focus on M&LE segment opportunities, disciplined cost control, and new product launches in the US market.
Board proposes equal split of profit distribution between dividend and share buyback.
Latest events from Colt CZ Group
- Net profit surged as ammunition growth offset U.S. firearms weakness; 2026 set for major gains.CZG
Q4 202525 Mar 2026 - Revenue and net profit surged, with acquisitions and bond issuance fueling future growth.CZG
Q3 202520 Nov 2025 - Ammunition-led growth and acquisitions drove higher revenues, with 2025 outlook reaffirmed.CZG
Q2 202518 Sep 2025 - Revenue up 51%, but net profit down on acquisition costs; guidance and leverage targets met.CZG
Q3 202413 Jun 2025 - Record H1 2024 revenue and EBITDA growth driven by Sellier & Bellot acquisition and US recovery.CZG
Q2 202413 Jun 2025 - Q1 2025 revenue up 50% and profit up 73%, with U.S. tariffs posing EBITDA risk.CZG
Q1 20259 Jun 2025